|
Awyr Your Sense of Smell Could Be Key to a Balanced Diet ISLAMABAD:The Pakistan Medical and Dental Council (PMDC) on Fri <a href=https://www.campusadidas.fr>adidas campus beige</a> day announced the schedule for the N <a href=https://www.inkwiz.se>ugg hausschuhe</a> ational Examination Board (NEB) examination Step-III. According to the schedule, examinations will be held on July 15,16, 22 and 23 at the Combined Military Hospital (CMH) in Rawalpindi for <a href=https://www.campusadidas.it>adidas original campus</a> medical students who have a foreign qualification. As many as 786 candidates are expected to appear in the examination. The PMDC will conduct the NEB Clinical examination in collaboration with the National University of Medical Sciences (NUMS) under the supervision of Vice Chancellor Lt Gen Syed Imran Majeed and PMDC Vice President Prof Dr Abid Farooqi.聽 PMDC Acting Registrar Dr Syed Azhar Ali Shah said that the Step-III exam has been spread over four parts and results of the examination would be released on the PMDC website the same day. He added that 80 renowned professors from all over the country have been invited to monitor the exam.Published in The Express Tribune, July 15th, 2017. Faced with the epidemic of opioid addiction, researchers have been charged with finding other strategies to treat pain. Their efforts largely have focused on nerve cells that transmit pain signals to the spinal cord and brain. But new research, led by scientists at Washington University School of Medicine in St. Louis, shows that targeting receptors on immune cells may be more effective, particularly for chronic pain.Recently, a non-opioid, investigational drug called EMA401 has shown promise as a treatment for lingering nerve pain <a href=https://www.nike-dunk.it>nike dunk uomo</a> following shingles infection. While trying to understand how that drug helped control pain, the Washington University research team was surprised to find that it doesn't hit nerve <a href=https://www.adidas-yeezys.com.mx>yeezy 700</a> cells; rather, it targets a receptor on immune cells.Their findings are published July 2 in The Journal of Neuroscience."We are in dire need of good pain-killing drugs, particularly non-opioid drugs," said principal investigator D.P. Mohapatra, P <a href=https://www.nikeairforces.de>air force1</a> hD, an associate professor in anesth |